Aurobindo Pharma gets warning letter from USFDA for API facility
on Friday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an ...
on Friday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an ...
has initiated talks with private equity funds to sell a stake of around 30-35% in its injectable business for ₹4,500-5,250 ...
Limited has launched COVID-19 treatment drug Molnupiravir under brand name "Molnaflu" in India. Molnupiravir is for treatment of adult patients ...
Drug maker named K.Nithyananda Reddy, as vice chairman and managing director of the company. Reddy who is part of the ...
Aurobindo Pharma on Tuesday said that its COVID-19 vaccine UB-612 programme hasn't progressed, as its partner Vaxxinity failed to secure ...
on Tuesday said that its COVID-19 vaccine UB-612 programme hasn't progressed, as its partner Vaxxinity failed to secure the emergency ...
Pharmaceuticals and are recalling multiple products in the US market due to various reasons like deviation from standard manufacturing protocols ...
Drug firm on Friday said N Govindarajan has tendered his resignation as the managing director and a director on the ...
New Delhi: Drug firm Aurobindo Pharma on Friday said its arm Eugia Pharma Specialities has received approval from the US ...
Aurobindo Pharma Ltd on Friday said its Rs 420-crore deal to acquire 51 per cent stake in Cronus Pharma Specialities ...
Copyright © 2021 Asia Post.
Asia Post is not responsible for the content of external sites.